Welcome to the Future of Healing™


Discover. Tomorrow. Today.

Triamino™, TAFA400™, and PH-713™ are revolutionary formulations that regenerate cells in the body.

Think about that for a moment.

There exists, today, a cellular-regeneration technology that is as clean and safe as the purest water … all natural … effective across a wide variety of conditions … applied in a variety of ways – topically, intravenously, orally, through an inhaler – depending on the condition.

This is not an empty claim. It is backed by over 2,000 human and over 900 animal case studies carefully documented by some of the world’s leading healthcare practitioners in nearly every discipline.

We invite you to explore our website. Read the case studies. View the videos. Read what’s new. If you have any questions or want to learn more, contact us.

The Latest Luminec News

Our Mission

“In addition to offering transformational healing products throughout the developed world, it is our goal to provide underprivileged individuals in third world countries with a unique stand-alone formula in the form of a broad-spectrum topical lotion for the treatment of diseases and most skin injuries (including burns). With full regard for basic human rights, it is our intent to deliver this product in a cost-effective manner never seen before.”
Steven R. Schutt and John Everding, Founders


Proven Success

5-YR-OLD TRIPPER INHALES TAFA400

In the last ten years, Luminec Pharmaceuticals has amassed over 2,000 human and over 900 animal case studies which demonstrate the healing power of our proprietary cellular-regeneration formulations, Triamino™, TAFA400™, and PH-713™, when applied to a wide variety of medical conditions. Our patients are treated by an elite medical and scientific team who have combined the formulations Triamino™, TAFA400™, and PH-713™, based on the Schutt Paradigm of Free Amino Ion Alignment & Molecular Stability, with a nutrition program customized for each patient to fortify the patient’s immune systems to maximum levels.

  • Patient: Annette Olguin
    Condition: Chronic Lymphocytic Leukemia

    annette-olguinThis patient continues to thrive on our program. She has had great energy, doesn’t feel sick, and works out now 4-5 times per week walking and doing other light workouts at the gym. It appears that the use of the TAFA400™ in IV format immediately following the chemo therapy was a total success.

    READ MORE
  • Patient: Jeanne Scolnick
    Condition: Lyme Disease

    Prior to beginning our treatments, she was experiencing night sweats, but once she started our IV treatments, she noticed an incredible response. She noticed for the first time in decades that her joints were not in pain! She couldn’t believe it. She called me the next day and said, “I don’t know what’s in this stuff, but I feel amazing!” She went on to describe how over the next several weeks she had so much energy, she was running around like a teenager …

    READ MORE
  • Patient: Sylvia Cottrell
    Conditions: Multiple Myeloma, Kidney Failure

    Sylvia Cottrell is a 66-year-old African American woman who presented to us in the spring of this year with complaints of Multiple Myeloma and Kidney Disease. Despite less than optimal compliance, we did see some significant improvements. Her mood seemed to be much improved, as was her energy level: from barely walking 50 feet, she now walks well over 200 feet—and asks how much farther would we like her to walk?

    READ MORE


About Luminec Pharmaceuticals




OUR MANUFACTURING PARTNERS

U.S. Manufacturing
Luminec Pharmaceuticals
2142 Industrial Court
Suite F
Vista, CA 92081

Mexico/Central America/South America Manufacturing & Distribution

Philippines Distribution

Catala Corporation

India Distribution

Pending

China Distribution

Frank Zhang, Exclusive Asia

“Steven Schutt & Luminec Pharmaceuticals have achieved remarkable results, combining Triamino™ & Fulhold’s Fulvic Acid, creating TAFA400™.”

Stephen W. Leviers, Director & Chief Scientific Officer, Fulhold Pharma